GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Inc (NYSE:DCF) » Definitions » Change In Receivables

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Change In Receivables : $6.40 Mil (TTM As of Feb. 2024)


View and export this data going back to 2017. Start your Free Trial

What is BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Change In Receivables?

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's change in receivables for the quarter that ended in Feb. 2024 was $-1.93 Mil. It means BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Accounts Receivable increased by $1.93 Mil from Aug. 2023 to Feb. 2024 .

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's change in receivables for the fiscal year that ended in Aug. 2023 was $0.22 Mil. It means BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Accounts Receivable declined by $0.22 Mil from Aug. 2022 to Aug. 2023 .

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Accounts Receivable for the quarter that ended in Feb. 2024 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Days Sales Outstanding for the six months ended in Feb. 2024 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's liquidation value for the six months ended in Feb. 2024 was $-55.39 Mil.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Change In Receivables Historical Data

The historical data trend for BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Change In Receivables Chart

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Annual Data
Trend Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Change In Receivables
Get a 7-Day Free Trial 3.05 -3.34 0.21 1.44 0.22

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Semi-Annual Data
Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 2.70 -1.26 -8.11 8.33 -1.93

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Feb. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $6.40 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund  (NYSE:DCF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Days Sales Outstanding for the quarter that ended in Feb. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/12.607*91
=0.00

2. In Ben Graham's calculation of liquidation value, BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's accounts receivable are only considered to be worth 75% of book value:

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's liquidation value for the quarter that ended in Feb. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.604-55.993+0.75 * 0+0.5 * 0
=-55.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Change In Receivables Related Terms

Thank you for viewing the detailed overview of BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Inc (NYSE:DCF) » Definitions » Change In Receivables
Comparable Companies
DMF HEQ JHS PFD WEA DMO SPE BWG BTA NAZ BLK BX OSTO:INVE A TSX:BN KKR APO BK AMP XSWX:PGHN LSE:III
Traded in Other Exchanges
N/A
Address
c/o BNY Mellon Investment Adviser, Inc., 240 Greenwich Street, New York, NY, USA, 10286
Website
https://www.bnymellonim.com
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Inc is a diversified closed-end management investment company. Its investment objectives are to seek high current income and to return at least the Fund's original NAV to holders of record of common shares on or about the termination date.
Executives
Bushra Mannan other: Director of BNYMIA (1) C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Irene Papadoulis other: Director of BNYMIA (1) C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Ping Jiang other: Dir. of Invest. Oversight (1) C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Bradley J Skapyak officer: President 200 PARK AVENUE, NEW YORK NY 10166
Joseph Martella officer: VP C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10288
Daniel Goldstein officer: VP 240 GREENWICH STREET, NEW YORK NY 10286
Robert J. Pomeroy officer: VP; Investment Adviser C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Vinay Patel other: Head of Finance of Sub-Adviser 200 PARK AVE, NEW YORK CITY NY 10166
Alcentra Ny, Llc other: Sub-Adviser 200 PARK AVENUE, 7TH FLOOR, NEW YORK NY 10166
Brandon Chao other: Portfolio Mgr of Sub-Adviser 200 PARK AVENUE, NEW YORK CITY NY 10166
Laurence Raven other: Portfolio Mgr of Sub-Adviser 200 PARK AVENUE, NEW YORK CITY NY 10166
Ross Curran other: Portfolio Mgr of Sub-Adviser 200 PARK AVENUE, NEW YORK CITY NY 10166
Cathy Bevan other: Portfolio Mgr of Sub-Adviser 200 PARK AVENUE, NEW YORK CITY NY 10166
Daire Wheeler other: Portfolio Mgr of Sub-Adviser 200 PARK AVENUE, NEW YORK CITY NY 10166
Eric Larsson other: Portfolio Mgr of Sub-Adviser C/O ALCENTRA NY LLC, 200 PARK AVENUE, NEW YORK CITY NY 10166